Cohu COHU stock outlook 2026 semiconductor test handler and contactor
US Stocks

Cohu (COHU) Stock Outlook 2026: Test Handlers, Contactor Recurring Revenue, and Cycle-Trough Leverage

Daylongs ·
#COHU #Cohu #US Stocks #Semiconductor Equipment #Semiconductor Test #Back-End Test #Automotive Semiconductors #Cyclical Stocks

Start with the structure before you value Cohu

Most investors who open up Cohu get pulled in two directions. One instinct says “semiconductor equipment, so this rides the same AI-datacenter wave as the big names.” The other asks “then why do the results swing on automotive and industrial inventory talk rather than on GPUs?” My read is that the whole thing clicks into place once you anchor on a single fact: Cohu does not build chips. It sells the gear that checks whether a finished chip is good or defective.

Here is the honest summary. Cohu is a two-faced stock. One face is a textbook cyclical equipment vendor selling test handlers and inspection tools. It earns a lot when chipmakers ramp back-end capex and it shrinks fast when they pull back. The other face is a recurring-revenue business that keeps selling the contactors, sockets, and spares that wear out inside gear already installed on customer floors. How the weight shifts between those two faces is, more or less, the entire Cohu thesis.

So Cohu is neither a clean bet on the equipment-order cycle nor a clean bet on consumable compounding. It is both levers at once: how much the recurring stream cushions the floor at the trough, and how forcefully deferred equipment orders come back when the cycle turns. That makes it appealing for anyone buying near a cycle low to capture the recovery, but the danger is misjudging how deep and how long that low runs. Get the trough wrong and you wait longer than you planned.

👉 For a neighboring back-end supply-chain name that rides its own capex cycle, read the PLAB Photronics stock outlook alongside this.


Where Cohu sits in the chip flow

A chip goes design → front-end (wafer fabrication) → back-end (packaging and test). Cohu lives in that final test stage, where a chip is screened to confirm it works to spec and stays reliable across temperature swings. Miss a defect here and it ends up in an automotive ECU or a phone, where it turns into a far more expensive recall later. That is exactly why automotive and industrial parts get tested longer and harder.

Break down what Cohu sells at this stage into four buckets and it gets easy to reason about.

First, test handlers. Robotic gear that automatically picks up thousands of chips, cycles them through temperature chambers, presses them against the tester, and sorts them into good and bad bins. Cohu offers pick-and-place, gravity, and turret handler lines for different device types.

Second, contactors and sockets. The consumable interface that connects a chip’s leads to the tester’s signals. As we will see, this is the beating heart of the recurring model.

Third, test systems (ATE). The box that actually applies and measures electrical signals. Cohu entered this in earnest through the 2018 Xcerra deal, though here it faces far larger rivals in Teradyne and Advantest.

Fourth, inspection, metrology, and software. Optical inspection and data analytics that lift yield and productivity across the whole test cell.

Product lineRoleRevenue character
Test handlersMove, temperature-control, and sort chipsEquipment (cyclical)
Contactors and socketsPhysical chip-to-board connectionConsumable (recurring)
Test systems (ATE)Apply and measure electrical signalsEquipment (competitive, subscale)
Inspection, metrology, SWImprove yield and productivityEquipment plus service

The point is that these buckets behave differently. Handlers and ATE are cyclical capital goods; contactors, sockets, spares, and services are recurring revenue that flows regardless of the order cycle. Cohu’s strategy is to grow the back half so it cushions the volatility of the front half.


Contactor recurring revenue: how strong is the blade, really?

Contactors are what set Cohu apart from a generic equipment vendor, and getting the economics right tells you why the company wants to be valued differently.

A contactor physically touches a chip’s leads on every test. Metal pins or probes wear down after hundreds of thousands of touchdowns and lose reliability, so they get replaced. On top of that, every time a chip’s package changes (pin layout, size, shape) the customer needs a fresh, dedicated contactor. In other words, sell the handler once and the worn-out contactor keeps selling itself afterward.

Two things make this powerful.

First, the recurring floor thickens as the installed base grows. The more Cohu handlers sit on OSAT (outsourced assembly and test) and IDM (integrated device maker) lines worldwide, the more contactor and spare revenue flows even in a year when no one buys new equipment. That is the cushion under the trough.

Second, there is switching friction. A customer already running contactors and a workflow tuned to a specific handler line has to requalify and re-verify yield to move to a rival consumable. On lines with extreme reliability demands, such as automotive, that requalification burden discourages switching.

Now the sober part. Cohu’s recurring stream is real, but it is not as thick as a classic consumable-compounder where the razor blades dominate the mix. Equipment still drives the cycle, and recurring revenue cushions the floor rather than erasing the cycle. That is why tracking the recurring-mix trend each quarter matters. If that share structurally grinds higher, Cohu earns the right to a valuation premium over time. If it stalls, the market keeps treating it as a pure cyclical.

👉 For the same installed-base-plus-aftermarket logic in an industrial setting, the Ingersoll Rand stock outlook is a useful comparison, since its aftermarket and consumables cushion the equipment cycle in much the same way.


Why Cohu’s results swing on automotive and industrial inventory

Cohu is more sensitive to the automotive and industrial semiconductor cycle than to an Nvidia-style datacenter ramp, and there is a concrete reason. Its end-market exposure leans heavily on analog, power, and microcontroller (MCU) chips used in cars and industrial systems.

These parts do not race down the leading-edge process node, but they are demanding to test. Wide temperature ranges, extreme reliability standards, and long test times. Long tests and heavy contactor wear are good for Cohu. The catch is that this market is deeply cyclical.

Automotive and industrial chips worked through a stretch of post-pandemic excess inventory across 2023 and 2024. As carmakers and industrial customers drew down chip stock, chipmakers deferred back-end equipment orders, and back-end vendors like Cohu took the hit on equipment revenue. The recurring stream did cushion the floor, but not enough to offset the equipment drop entirely.

PhaseDownstream chip demandCohu earnings mechanism
Excess and correctionAuto and industrial destockOrders deferred, revenue falls, only recurring remains
NormalizationProduction restartsUtilization recovers, order signals return
Recovery and expansionNew chips and packages rampDeferred orders bunch up plus fresh contactor demand
Overheat and peakBack-end capacity maxed outEquipment revenue peaks, inventory risk builds

The investment takeaway is blunt: Cohu offers big recovery leverage if you buy near the trough, but the exact bottom is hard to see in advance. A correction can end in six months or drag on well past that. Scale in near the low rather than all at once, and ground your trough call in leading indicators like utilization and book-to-bill, which we cover below.


How hard does it snap back? The reality of recovery leverage

The appeal of a cyclical equipment stock lives in the recovery. At the trough, fixed costs and low utilization crush margins; when revenue returns, operating leverage kicks in and profit grows far faster than sales. Cohu follows this pattern.

Three forces drive the snap-back.

First, deferred demand bunches up. Orders postponed during the correction cluster at the start of the recovery. When customers try to add capacity at the same time, near-term bookings spike.

Second, new chips and packages ripple through. Vehicle electrification, industrial automation, and the spread of power semiconductors are structural currents that create new chips and new packages. Each new package needs a dedicated contactor, so recovery is not just the return of old demand but a way to enlarge the recurring base itself.

Third, mix improves the quality of earnings. Recurring revenue generally carries better margins and predictability. If its share steps up through each cycle, the earnings floor at the next trough sits higher than the last. That is the picture Cohu is chasing: raise the floor a notch every time it rides the cycle.

Recovery leverage cuts both ways, of course. Profit that explodes in the good times can vanish, even flip to a loss, in the bad. That is why Cohu is better judged by cycle position than by trailing results. The moment earnings look best may be the peak, and the moment they look most dismal may be the buying opportunity. If you want a framework for separating signal from hype across the broader AI and semiconductor theme, work through the AI stocks investment guide 2026 for a selection discipline.


Cohu vs its peers: placing it on the back-end test map

To position Cohu properly, line it up against the rest of the back-end test ecosystem, which splits roughly into the box that measures (ATE) and the periphery that moves and contacts the chip (handlers, contactors, probes).

CompanyCore focusPosition vs Cohu
Cohu (COHU)Handlers, contactors, inspection, some ATEStrong in interface and handlers, subscale in ATE
Teradyne (TER)Leading SoC and memory ATE, some handlersLarger, dominant in ATE
AdvantestOne of the two ATE giantsATE and HBM test leader, far larger
FormFactor (FORM)Probe cards (wafer test interface)Adjacent and partial competitor in interface consumables
Aehr Test SystemsBurn-in and reliability testNiche reliability test, partial competitor

The table reveals Cohu’s identity. It is not an ATE giant like Teradyne or Advantest, and it loses a head-to-head scale fight on pure signal-measurement performance. Its home turf is moving the chip (handlers) and physically contacting it (contactors and sockets). That interface layer throws off consumable recurring revenue, so the quality of the business is genuinely different.

The question to ask is this. Does Cohu stay a subscale equipment supplier grinding against ATE giants on price, or does it widen a distinct moat in the handler and contactor interface and earn a recurring-revenue premium? Whether that second picture plays out is the crux of any long-term re-rating. It helps to note that FormFactor, a probe-card specialist rooted in interface consumables, gets a relatively steadier reception through cycles, which is a proof point for the direction Cohu is aiming at.


Cohu investment risks: a reality check on the bull case

The recovery-leverage story is attractive, but weigh these risks seriously.

Depth and length of the trough. The most direct risk. If the automotive and industrial correction lingers, the equipment recovery slips and margins stay compressed under low utilization. The opportunity cost of waiting can be larger than it looks.

Customer concentration and lumpy orders. A single large OSAT or IDM order decision can swing a quarter. One big customer’s capex delay translates straight into a Cohu earnings miss.

Larger competitors. In ATE, the scale and R&D budgets of Teradyne and Advantest dwarf Cohu. If they push integrated handler-plus-interface solutions, they can pressure Cohu’s home turf.

China exposure and export controls. China is a large market for back-end equipment, but US-China tech tension and export rules add uncertainty across the group. Tighter controls can constrain revenue to specific regions or customers.

Limits of recurring revenue. As stressed above, the recurring stream cushions but does not cancel the cycle. If the recurring mix stops rising, the market can revert to treating Cohu as a volatile pure cyclical and strip out the premium.

Because Cohu rewards a “buy when others are fearful and wait for the turn” temperament, the cycle-timing logic in a comparably cyclical name like the United Rentals stock outlook is worth borrowing, since both live and die on where the capital-spending cycle sits.


Three practical scenarios for US investors

Scenario 1: scale in at the trough, bet on recovery leverage

Cohu suits staged buying keyed to cycle position more than steady dollar-cost averaging. When the automotive and industrial correction is underway and the stock has been beaten down, rather than committing all at once, add in tranches as utilization and book-to-bill signal a base forming. Aim to cover the “near-the-low zone” rather than nail the exact bottom. Given the volatility, cap a single-name position modestly and lean in only once the cycle has clearly turned.

Scenario 2: managing the tax bill on a cyclical

For a US taxable account, holding period drives the tax outcome. Sell within a year and gains are taxed as short-term at ordinary rates; hold beyond a year and they qualify for long-term capital gains rates. With a swingy name like Cohu, the temptation is to trade every move, but crossing the one-year line before selling a big winner can materially improve after-tax returns. Tax-loss harvesting is the flip side: in a deep correction, realizing a loss on a Cohu position to offset gains elsewhere can be sensible, as long as you respect the wash-sale rule if you plan to buy back. The broader mechanics are laid out in the capital gains tax guide 2026.

Scenario 3: hold long term on the recurring-revenue trajectory

If short-cycle trading is not your style, anchor the decision on the structural rise of the recurring mix instead. If recurring revenue steps higher each quarter and the trough revenue floor sits above the prior cycle’s, the case for re-rating Cohu from pure cyclical to recurring-premium compounder is building. If that share stalls for years, assume the underlying character has not changed, however good the cycle looks, and temper expectations. If a portfolio of growth-plus-cyclical names feels top-heavy, pairing a steady income sleeve such as the SCHD dividend ETF guide 2026 is a realistic ballast.


Monitoring Cohu: the metrics to watch each quarter

Watch only headline revenue growth and you will miss the cycle. These indicators tell you where in the cycle you actually are.

Priority 1: utilization of the installed base. Cohu tends to cite system utilization as a leading cycle indicator. When utilization lifts off the bottom, customers are likely to restart equipment orders soon. Persistently low utilization says the equipment recovery is still far off.

Priority 2: backlog and book-to-bill. A book-to-bill above 1 means orders exceed shipments, an early recovery signal. Below 1 says the correction is not over.

Priority 3: recurring revenue as a percent of sales. The core thesis of this whole piece. Check whether contactors, spares, and services are trending up as a share of revenue. The direction of this number decides whether Cohu re-rates.

Priority 4: end-market commentary. How management describes inventory and demand across automotive, industrial, mobility, and computing sets up the next quarter’s direction. A comment that automotive and industrial inventory has “normalized” is a clue to the cycle turn.

Priority 5: gross margin and breakeven. How well margins hold at the trough reveals the cost structure and the strength of the recurring cushion. If the trough margin floor rises as recurring mix grows, that is strong evidence the quality of the business is improving.

Put these five together and you can read past the “revenue grew X percent” headline to the cycle position and the qualitative shift in the business.


Further reading


This article is an investment opinion written for informational purposes and does not recommend buying or selling any specific security. Investing carries the risk of losing principal, and every investment decision should be made by you after weighing your own financial situation and risk tolerance. The business conditions and outlook described here reflect the time of writing; always verify the latest disclosures and consult a qualified professional before investing.

What does Cohu (COHU) actually do?

Cohu makes equipment for the back-end test stage of semiconductor manufacturing. It sells test handlers that move chips through temperature testing, contactors that physically connect a chip to the test board, inspection and metrology tools, and test systems (ATE). Its 2018 acquisition of Xcerra pushed it from a handler-centric company into a broader back-end equipment supplier.

Why is Cohu described as a razor-and-blade model?

Sell a handler once (the razor) and you keep selling the contactors, sockets, and spares that wear out inside it (the blades). Contactors physically touch each chip during testing and degrade over time, so the installed base keeps generating consumable revenue even in years when no new equipment ships.

What exactly is a contactor?

A contactor is the consumable interface inside a test handler that bridges a chip's leads to the tester's electrical signals. After hundreds of thousands of touchdowns it wears out and must be replaced, and every new chip package requires its own dedicated contactor. That repeat-replacement demand is the heart of Cohu's recurring revenue.

Why is Cohu's stock so cyclical?

Equipment revenue tracks the back-end capital spending of chipmakers. When automotive and industrial chip demand rolls over into an inventory correction, customers defer new test equipment orders and Cohu's equipment sales fall hard. When the cycle turns, deferred orders bunch up and earnings leverage is significant.

Which end markets does Cohu depend on most?

Automotive and industrial semiconductors carry heavy weight, alongside mobility (smartphones), computing, and consumer chips. Automotive and industrial parts are analog, power, and MCU heavy, which means long test times and high contactor wear that favor Cohu, but it also ties earnings tightly to those two markets' inventory cycles.

How does Cohu compare with Teradyne and Advantest?

Teradyne and Advantest are the two giants of the test-system (ATE) market and are far larger than Cohu. Cohu's relative strength is in test handlers and the contactor and socket interface. In short, Cohu is strong at moving and contacting the chip and is a smaller player in the ATE box that measures the electrical signal.

Does Cohu pay a dividend?

Cohu has historically favored share repurchases, reinvestment, and preserving acquisition capacity over a dividend. Treat it as a growth-plus-cyclical name that pays off on recovery and recurring-revenue growth rather than as an income holding. Capital-return policy can change, so check the latest disclosures.

Why does a rising recurring-revenue mix matter for Cohu?

The larger the share of contactors, spares, and services in total revenue, the more the down-cycle revenue floor is cushioned. Higher recurring mix means lower earnings volatility than a pure equipment vendor and a case for a valuation premium, which is exactly the direction Cohu emphasizes strategically.

How are US investors taxed on a Cohu position?

For a US taxable account, gains on Cohu depend on holding period. Shares held one year or less are taxed as short-term gains at ordinary income rates, while shares held longer than a year qualify for long-term capital gains rates. Holding a cyclical like Cohu long enough to cross the one-year line can matter meaningfully to after-tax returns.

Which metrics should I watch every quarter with Cohu?

Recurring revenue as a percentage of sales, backlog and book-to-bill, utilization of the installed base, management commentary by end market (automotive, industrial, mobility), and gross margin trend. Utilization tends to lead future equipment orders.

What is the biggest risk in owning Cohu?

The depth and duration of the cycle trough. If the automotive and industrial inventory correction drags on longer than expected, the equipment-revenue recovery is delayed. Customer concentration, competition from much larger ATE peers, and China exposure with export-control risk round out the list.

공유하기

관련 글